Literature DB >> 9672078

Conjugated equine estrogens alone, but not in combination with medroxyprogesterone acetate, inhibit aortic connective tissue remodeling after plasma lipid lowering in female monkeys.

T C Register1, M R Adams, D L Golden, T B Clarkson.   

Abstract

The objective of this study was to determine the arterial responses to plasma lipid lowering alone or in combination with (1) estrogen replacement therapy or (2) hormone replacement therapy in surgically postmenopausal female monkeys with preexisting atherosclerosis. Eighty-eight female cynomolgus macaques were ovariectomized, fed an atherogenic diet for 24 months, and then assigned by randomized stratification into 4 groups. One group (baseline, n=20) was necropsied at the end of the atherogenic diet period; the remaining 3 groups were fed a plasma lipid-lowering diet (regression) for 30 months. These regression groups were control (diet only), CEE (receiving conjugated equine estrogens alone), and CEE+MPA (receiving CEE and continuous medroxyprogesterone acetate). A previous report described coronary artery functional and histological results; the present report describes biochemical and histological results from the abdominal aorta. Aortic plaque size was not different between groups, similar to previous findings in the coronary arteries. Aortic cholesterol content (milligrams per gram lipid-free dry weight) was lower in the regression groups compared with baseline, both for free cholesterol (mean, control=19.1, CEE=15.7, CEE+MPA=14.4, and baseline=32.7; P<0.001) and for esterified cholesterol (mean, control=18.9, CEE=15.4, CEE+MPA=14.2, and baseline=58.7; P<0.001). This cholesterol efflux could lead to increased plaque stability without changing the physical size of the lesion. Alterations in aortic connective tissue composition were observed in the regression groups. When expressed as a percentage of the lipid-free tissue weight, the aortic elastin content of the control (mean=14.9) and the CEE+MPA (mean=14.0) groups was lower than that of the baseline group (mean=19.0), which was not different from that of the CEE group (mean=15.8). Aortic collagen content, as estimated by hydroxyproline content per milligram of lipid-free tissue, was higher in the control group (mean=67.4) and the CEE+MPA group (mean=66.1) than in the baseline group (mean=56.2; P<0.05). Collagen content of the CEE group (mean=58.9) was not different from that of the baseline group. When the regression groups were considered separately, the aortic collagen content of the CEE group was lower than that of the control group (P<0.05) and tended to be lower than that of the CEE+MPA group (P=0.10), suggesting that CEE therapy (but not CEE+MPA) inhibits potentially detrimental connective tissue alterations that accompany lesion regression. These results have implications for combinations of lipid-lowering and hormone replacement therapies in relation to vascular remodeling and abdominal aortic aneurysm development.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9672078     DOI: 10.1161/01.atv.18.7.1164

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  14 in total

Review 1.  Normal genetic variation, cognition, and aging.

Authors:  P M Greenwood; Raja Parasuraman
Journal:  Behav Cogn Neurosci Rev       Date:  2003-12

2.  Estrogen receptor alpha is a major mediator of 17beta-estradiol's atheroprotective effects on lesion size in Apoe-/- mice.

Authors:  J B Hodgin; J H Krege; R L Reddick; K S Korach; O Smithies; N Maeda
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

Review 3.  Potential approaches to enhance the effects of estrogen on senescent blood vessels and postmenopausal cardiovascular disease.

Authors:  Raouf A Khalil
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2010-01

Review 4.  Hormone replacement therapy in the prevention and treatment of atherosclerosis.

Authors:  L Mosca
Journal:  Curr Atheroscler Rep       Date:  2000-07       Impact factor: 5.113

Review 5.  Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vessels.

Authors:  Dia A Smiley; Raouf A Khalil
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

6.  Differential effects of estradiol on carotid artery inflammation when administered early versus late after surgical menopause.

Authors:  Areepan Sophonsritsuk; Susan E Appt; Thomas B Clarkson; Carol A Shively; Mark A Espeland; Thomas C Register
Journal:  Menopause       Date:  2013-05       Impact factor: 2.953

7.  Cholesterol-fed ovariectomized monkeys are good animal models for human atherosclerosis of postmenopausal women.

Authors:  Ryuzo Torii; Masashi Shiomi; Takashi Ito; Satoshi Yamada; Yutaka Eguchi; Norimichi Ikeda
Journal:  Primates       Date:  2003-04-25       Impact factor: 2.163

Review 8.  Why primate models matter.

Authors:  Kimberley A Phillips; Karen L Bales; John P Capitanio; Alan Conley; Paul W Czoty; Bert A 't Hart; William D Hopkins; Shiu-Lok Hu; Lisa A Miller; Michael A Nader; Peter W Nathanielsz; Jeffrey Rogers; Carol A Shively; Mary Lou Voytko
Journal:  Am J Primatol       Date:  2014-04-10       Impact factor: 2.371

9.  Timing of estrogen replacement influences atherosclerosis progression and plaque leukocyte populations in ApoE-/- mice.

Authors:  Jennifer A Cann; Thomas C Register; Michael R Adams; Richard W St Clair; Mark A Espeland; J Koudy Williams
Journal:  Atherosclerosis       Date:  2008-02-21       Impact factor: 5.162

10.  Experimental benefits of sex hormones on vascular function and the outcome of hormone therapy in cardiovascular disease.

Authors:  Reagan L Ross; Michelle R Serock; Raouf A Khalil
Journal:  Curr Cardiol Rev       Date:  2008-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.